Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Int Clin Psychopharmacol ; 27(2): 121-4, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22113252

RESUMEN

St John's wort (Hypericum perforatum) is notorious for its ability to induce the enzymes of the P450 system. Especially, it induces CYP1A2 and CYP3A4, enzymes that are closely involved in the metabolism of clozapine. We present a patient with schizophrenia, who was stable on a fixed dose with stable plasma level of clozapine, and who deteriorated after she started self-medicating with St John's wort. The reduced plasma clozapine level and the psychiatric condition normalized after the withdrawal of St John's wort. It is possible that, beside the induction of P450-enzymes, the induction of P-glycoprotein by St John's wort aggravated psychiatric deterioration of the patient. Physicians should be alert to patients self-medicating with over-the-counter medicines, especially when these medicines can lower clozapine concentrations below the therapeutic range.


Asunto(s)
Antipsicóticos/uso terapéutico , Clozapina/uso terapéutico , Interacciones de Hierba-Droga , Hypericum/química , Preparaciones de Plantas/efectos adversos , Esquizofrenia Hebefrénica/tratamiento farmacológico , Adulto , Antipsicóticos/sangre , Antipsicóticos/farmacocinética , Clozapina/sangre , Clozapina/farmacocinética , Resistencia a Medicamentos , Femenino , Humanos , Esquizofrenia Hebefrénica/fisiopatología , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...